Altered brain dynamics in Parkinson’s disease patients treated by deep brain stimulation
Objective: The presented work explores electrophysiological changes in brain dynamics described by EEG microstates and the effect of deep brain stimulation (DBS) of subthalamic nucleus…COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease
Objective: We examined the influence of single nucleotide polymorphisms (SNPs) in specific genes on levodopa-induced dyskinesia development in Parkinson’s disease patients Background: Levodopa-induced dyskinesia (LID)…JourneyMap: A visual resource to reduce coordinator burden during virtual study visits
Objective: Reduce burden on research team members and study participants during remote deployment of a touchless sensor device for in-home use with people with Parkinson’s…Virtual Visit Experience of the Portland Oregon Pacific UDALL Center During COVID-19
Objective: To retain a well-characterized longitudinal Parkinson’s Study, The Portland Oregon Pacific UDALL Center (PRE-PUC) cohort, during the pandemic years. Background: Although best known for…Environmental exposures and clinical phenotype in a sample of patients with Parkinson’s disease in the southwestern Colombian region: preliminary results
Objective: Describe the clinical phenotype and environmental agents of patients from the Colombian southwestern region with familiar and sporadic Parkinson’s disease in a sample Background:…Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease
Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and the potential effect of gut microbiota on pre-motor…Analyzing the metabolic function of DJ-1 in the pathogenesis of Parkinson`s disease (PD) and Glioblastoma multiforme (GBM)
Objective: In this project, we are comprehensively studying the function of DJ-1 in PD and GBM to better understand its observed role in both, neurodegeneration…A Pilot Feasibility Study of Medium Chain Triglyceride Nutritional Ketosis and Parkinson’s Disease
Objective: To determine if nutritional ketosis supplemented by medium chain triglycerides (MCT) over the course of 2-3 weeks is acceptable and feasible in patients with…Face Name matching and memory complaints in Parkinson’s disease
Objective: We aim to portray memory impairment in patients with Parkinson’s disease (PD) from an objective and subjective angle by using an innovative cross-modal associative…A progress update on the Critical Path for Parkinson’s consortium’s pre-competitive 3DT initiative
Objective: To provide a progress update on the Critical Path for Parkinson’s (CPP) consortium’s “Digital Drug Development” (3DT) initiative, which was established in 2019 with…
- « Previous Page
- 1
- …
- 336
- 337
- 338
- 339
- 340
- …
- 436
- Next Page »
